These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3063169)

  • 1. Mode of action of morpholine derivatives.
    Polak A
    Ann N Y Acad Sci; 1988; 544():221-8. PubMed ID: 3063169
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antifungal resistance in opportunistic pathogenic fungi (II). Imidazoles and triazoles].
    Martínez-Suárez JV; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):490-8. PubMed ID: 9011208
    [No Abstract]   [Full Text] [Related]  

  • 3. Agar sublimation test for the in vitro determination of the antifungal activity of morpholine derivatives.
    Polak A; Jäckel A; Noack A; Kappe R
    Mycoses; 2004 Jun; 47(5-6):184-92. PubMed ID: 15189181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oxiconazole and Ro 14-4767/002 on sterol pattern in Candida albicans.
    Polak-Wyss A; Lengsfeld H; Oesterhelt G
    Sabouraudia; 1985 Dec; 23(6):433-41. PubMed ID: 3913013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cross-resistance of Candida albicans to several different families of antifungals with ergosterol biosynthesis-inhibiting activity].
    Hiratani T; Yamaguchi H
    Jpn J Antibiot; 1994 Feb; 47(2):125-8. PubMed ID: 8151906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the morpholine derivate amorolfin (Roche 14-4767/002) on the ultrastructure of Candida albicans.
    Müller J; Polak A; Jaeger R
    Mykosen; 1987 Nov; 30(11):528-40. PubMed ID: 3328047
    [No Abstract]   [Full Text] [Related]  

  • 7. [In vitro antifungal activity of amorolfine, a new morpholine antimycotic agent].
    Hiratani T; Asagi Y; Matsusaka A; Uchida K; Yamaguchi H
    Jpn J Antibiot; 1991 Sep; 44(9):993-1006. PubMed ID: 1960861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of phagocytosis and intracellular killing of Candida albicans by human neutrophils in the presence of a morpholine antifungal derivative, Ro 14-4767.
    Richardson MD; Gray CA
    Ann N Y Acad Sci; 1988; 544():403-5. PubMed ID: 3063177
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on experimental chemotherapy of dermatomycosis and candidiasis. X. Mechanism of the antifungal action of propiolic acid (beta-naphthyl)methyl ester].
    Maeda T; Matui S; Hayashi M; Yamazoe H; Hayashi E
    Yakugaku Zasshi; 1986 Mar; 106(3):248-56. PubMed ID: 3522852
    [No Abstract]   [Full Text] [Related]  

  • 10. Morpholine antifungals and their mode of action.
    Mercer EI
    Biochem Soc Trans; 1991 Aug; 19(3):788-93. PubMed ID: 1783217
    [No Abstract]   [Full Text] [Related]  

  • 11. Thiophene congeners of morpholine and allylamine type antifungals--syntheses and biological activities.
    Bracher F; Papke T
    Pharmazie; 1995 Aug; 50(8):525-7. PubMed ID: 7568314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relative inhibition factors: a new approach to the evaluation of antifungal antibiotics in vitro].
    Odds FC
    Ann Dermatol Venereol; 1989; 116 Suppl 1():10-2. PubMed ID: 2688524
    [No Abstract]   [Full Text] [Related]  

  • 13. Mode of action of clinically important antifungal drugs.
    Kerridge D
    Adv Microb Physiol; 1986; 27():1-72. PubMed ID: 3532715
    [No Abstract]   [Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of novel 1, 2, 4-triazole derivatives as antifungal agent.
    Chai X; Yu S; Jiang Y; Zou Y; Wu Q; Zhang D; Jiang Y; Cao Y; Sun Q
    Arch Pharm Res; 2012 Nov; 35(11):1895-901. PubMed ID: 23212630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi.
    Wiederhold NP; Patterson TF; Srinivasan A; Chaturvedi AK; Fothergill AW; Wormley FL; Ramasubramanian AK; Lopez-Ribot JL
    Virulence; 2017 Feb; 8(2):138-142. PubMed ID: 27268469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis.
    Luna-Tapia A; Peters BM; Eberle KE; Kerns ME; Foster TP; Marrero L; Noverr MC; Fidel PL; Palmer GE
    Eukaryot Cell; 2015 Oct; 14(10):1006-16. PubMed ID: 26231054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal activity from Alpinia galanga and the competition for incorporation of unsaturated fatty acids in cell growth.
    Haraguchi H; Kuwata Y; Inada K; Shingu K; Miyahara K; Nagao M; Yagi A
    Planta Med; 1996 Aug; 62(4):308-13. PubMed ID: 8792660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of clotrimazole on Candida albicans.
    Beggs WH
    J Antimicrob Chemother; 1995 Oct; 36(4):742-3. PubMed ID: 8591954
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on arylmethyltriazinone derivatives-Part II. Synthesis and antifungal properties of 2-aminomethyl-4-(arylidene)amino-6-arylmethyl- 3-mercapto-1,2,4-triazin-5(4H)-ones.
    Holla BS; Gonsalves R; Shivananda MK
    Boll Chim Farm; 1998 Mar; 137(3):93-6. PubMed ID: 9611847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of Schiff bases of 4-(4-aminophenyl)-morpholine as potential antimicrobial agents.
    Panneerselvam P; Nair RR; Vijayalakshmi G; Subramanian EH; Sridhar SK
    Eur J Med Chem; 2005 Feb; 40(2):225-9. PubMed ID: 15694658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.